Use access key #2 to skip to page content.
$0.47 0.01 (2.13%)
10/10/2008 3:58 PM

Introgen Therapeutics, Inc. (INGN)

CAPS Rating:
*

A biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

INGN doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

70 Outperforms
95 Underperforms
 

All-Stars

14 Outperforms
52 Underperforms
 

Members bullish on INGN are also bullish on:

Members bearish on INGN are also bearish on:

Ticker Tags

Drug Related Products (25), Micro Cap (4824), Biotechnology (295)
Suggest a tag

Introgen Therapeutics, Inc. At A Glance

Current Price: $0.47
Last Trade Time: 10/10/2008 3:58 PM
Open: $0.40
Previous Close: $0.47
Daily Range: $0.40 - $0.50
52-Week Range: $0.35 - $4.67
Volume: 77,680
Market Cap: $20.70M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

INGN VS S&P 500 (SPY)

INGN 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for INGN

More Headlines...

Top Bull Pitch

Recs

1

Introgen Therapeutics, Inc. (INGN)

Avatar moto96793 (< 20) Submitted: 2/13/08 7:53 PM

if its in my portfolio, i will pick it here

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

Introgen Therapeutics, Inc. (INGN)

Avatar majakblue (< 20) Submitted: 6/23/07 4:02 PM

Okay, this one is easy. No products, no profit, going nowhere, no-brainer. Don't bet on pharma wannabes! Buy a lottery ticket instead. Much better odds. I am beginning to sound like a broken record. I'm gonna stop rating these biopharmaceutical start-ups, its getting boring.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 21 :   1 2 3 4 5 Next »

Show Pitch Replies

Recs

1

 (INGN)

Avatar moto96793 (< 20) Submitted: 2/13/08 7:53 PM : Outperform Start Price: $2.67 INGN Score: -47.02

if its in my portfolio, i will pick it here

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (INGN)

Avatar utosweet (69.44) Submitted: 2/04/08 6:22 PM : Underperform Start Price: $3.09 INGN Score: 49.89

A long with (GPCB) This USA company is very good for the cheap investor.Look for some news shortly !

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (INGN)

Avatar pro9185 (72.53) Submitted: 1/20/08 7:57 PM : Underperform Start Price: $2.78 INGN Score: 52.66

underpreform

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (INGN)

Avatar no12call (79.38) Submitted: 1/10/08 12:54 PM : Outperform Start Price: $2.84 INGN Score: -46.07

They have bottomed out. Now with the expanded trial and the great results for the second phase trial, if they receive a green light from Europe, the sky is the limit. Shrinking tumors and increasing my personal wealth! A win, win.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (INGN)

Avatar papelbon58 (< 20) Submitted: 11/01/07 9:35 PM : Outperform Start Price: $3.81 INGN Score: -46.07

I hope this stock will outperform. I will support any company tries to develop therapies for cancer treatment. It looks like it has some promise.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 21 :   1 2 3 4 5 Next »

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners